Apalutamide, a new hormonal tablet, has been found to improve survival of patients with metastatic, castration-sensitive prostate cancer .

The study was presented at the ASCO (American Society of Clinical Oncology) meeting at Chicago .

It is wonderful to have so many treatment options to treat advanced prostate cancer.

Reference

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

Disclaimer: Please note- This blog is NOT medical advice. This blog is purely for information only. See your own doctor to discuss concerns and options relevant for you.